Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Measurements of the radiographic cardiac silhouette of ospreys (Pandion haliaetus).

Woo KMT, Barron GH, Daugherty AL, Woo JMP, Kehoe SP, Aguilar LAB, Cavanaugh SM.

Am J Vet Res. 2019 Sep;80(9):840-845. doi: 10.2460/ajvr.80.9.840.

PMID:
31449449
2.

Ocular drugs and drug delivery systems - Current trends and future perspectives.

Rupenthal ID, Daugherty AL.

Drug Discov Today. 2019 Aug;24(8):1425-1426. doi: 10.1016/j.drudis.2019.07.005. Epub 2019 Jul 19. No abstract available.

PMID:
31330186
3.

Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis.

Throm AA, Alinger JB, Pingel JT, Daugherty AL, Pachman LM, French AR.

JCI Insight. 2018 Nov 15;3(22). pii: 123236. doi: 10.1172/jci.insight.123236.

4.

Correction: Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis (doi: 10.1242/dmm.030130).

Olson PD, McLellan LK, Liu A, Briden KE, Tiemann KM, Daugherty AL, Hruska KA, Hunstad DA.

Dis Model Mech. 2018 Sep 13;11(9). pii: dmm036798. doi: 10.1242/dmm.036798. No abstract available.

5.

Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry.

Throm AA, Moncrieffe H, Orandi AB, Pingel JT, Geurs TL, Miller HL, Daugherty AL, Malkova ON, Lovell DJ, Thompson SD, Grom AA, Cooper MA, Oh ST, French AR.

JCI Insight. 2018 Aug 9;3(15). pii: 121544. doi: 10.1172/jci.insight.121544. eCollection 2018 Aug 9.

6.

Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis.

Olson PD, McLellan LK, Liu A, Briden KE, Tiemann KM, Daugherty AL, Hruska KA, Hunstad DA.

Dis Model Mech. 2017 Nov 1;10(11):1371-1379. doi: 10.1242/dmm.030130. Epub 2017 Sep 7. Erratum in: Dis Model Mech. 2018 Sep 13;11(9):.

7.

Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response.

Thackaberry EA, Farman C, Zhong F, Lorget F, Staflin K, Cercillieux A, Miller PE, Schuetz C, Chang D, Famili A, Daugherty AL, Rajagopal K, Bantseev V.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4274-4285. doi: 10.1167/iovs.16-21334.

PMID:
28850638
8.

A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components.

Kinnunen HM, Sharma V, Contreras-Rojas LR, Yu Y, Alleman C, Sreedhara A, Fischer S, Khawli L, Yohe ST, Bumbaca D, Patapoff TW, Daugherty AL, Mrsny RJ.

J Control Release. 2015 Sep 28;214:94-102. doi: 10.1016/j.jconrel.2015.07.016. Epub 2015 Jul 22.

PMID:
26210441
9.

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration.

Zheng Y, Tesar DB, Benincosa L, Birnböck H, Boswell CA, Bumbaca D, Cowan KJ, Danilenko DM, Daugherty AL, Fielder PJ, Grimm HP, Joshi A, Justies N, Kolaitis G, Lewin-Koh N, Li J, McVay S, O'Mahony J, Otteneder M, Pantze M, Putnam WS, Qiu ZJ, Ruppel J, Singer T, Stauch O, Theil FP, Visich J, Yang J, Ying Y, Khawli LA, Richter WF.

MAbs. 2012 Mar-Apr;4(2):243-55. doi: 10.4161/mabs.4.2.19387. Epub 2012 Mar 1.

10.

Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis.

Daugherty AL, Rangell LK, Eckert R, Zavala-Solorio J, Peale F, Mrsny RJ.

Eur J Pharm Biopharm. 2011 Jun;78(2):289-97. doi: 10.1016/j.ejpb.2011.03.011. Epub 2011 Mar 21.

PMID:
21426936
11.

Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection.

Daugherty AL, Mrsny RJ.

J Drug Target. 2010 Jan;18(1):27-35. doi: 10.3109/10611860903134317.

PMID:
19624285
12.

Formulation and delivery issues for monoclonal antibody therapeutics.

Daugherty AL, Mrsny RJ.

Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):686-706. Epub 2006 May 22. Review.

PMID:
16839640
13.

Emerging technologies that overcome biological barriers for therapeutic protein delivery.

Daugherty AL, Mrsny RJ.

Expert Opin Biol Ther. 2003 Oct;3(7):1071-81. Review.

PMID:
14519072
14.

Bacterial toxins as tools for mucosal vaccination.

Mrsny RJ, Daugherty AL, McKee ML, FitzGerald DJ.

Drug Discov Today. 2002 Feb 15;7(4):247-58. Review.

PMID:
11839522
15.

Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes.

Lam XM, Duenas ET, Daugherty AL, Levin N, Cleland JL.

J Control Release. 2000 Jul 3;67(2-3):281-92.

PMID:
10825561
16.

Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node.

Daugherty AL, McKee ML, FitzGerald DJ, Mrsny RJ.

J Control Release. 2000 Mar 1;65(1-2):297-302.

PMID:
10699289
17.

Regulation of the intestinal epithelial paracellular barrier.

Daugherty AL, Mrsny RJ.

Pharm Sci Technolo Today. 1999 Jul;2(7):281-287.

PMID:
10407391
18.

Transcellular uptake mechanisms of the intestinal epithelial barrier Part one.

Daugherty AL, Mrsny RJ.

Pharm Sci Technolo Today. 1999 Apr;4(2):144-151.

PMID:
10322371
19.
20.

Characterization of V3 loop-Pseudomonas exotoxin chimeras. Candidate vaccines for human immunodeficiency virus-1.

FitzGerald DJ, Fryling CM, McKee ML, Vennari JC, Wrin T, Cromwell ME, Daugherty AL, Mrsny RJ.

J Biol Chem. 1998 Apr 17;273(16):9951-8.

21.

Percutaneous absorption of biologically-active interferon-gamma in a human skin graft-nude mouse model.

Short SM, Paasch BD, Turner JH, Weiner N, Daugherty AL, Mrsny RJ.

Pharm Res. 1996 Jul;13(7):1020-7.

22.

Distribution of DNA and alginate in purulent cystic fibrosis sputum: implications to pulmonary targeting strategies.

Mrsny RJ, Daugherty AL, Short SM, Widmer R, Siegel MW, Keller GA.

J Drug Target. 1996;4(4):233-43.

PMID:
9010813
23.

Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification.

Daugherty AL, Patapoff TW, Clark RC, Sinicropi DV, Mrsny RJ.

Biomaterials. 1995 May;16(7):553-8.

PMID:
7492720
24.

Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity.

Mrsny RJ, Lazazzera BA, Daugherty AL, Schiller NL, Patapoff TW.

Pulm Pharmacol. 1994 Dec;7(6):357-66.

PMID:
7549223
25.

Absorption of human growth hormone from the rat lung.

Patton JS, McCabe JG, Hansen SE, Daugherty AL.

Biotechnol Ther. 1989-1990;1(3):213-28.

PMID:
2562650

Supplemental Content

Loading ...
Support Center